|
Parameters
|
Subacute phase
|
Subchronic phase
|
|---|
|
Treatment group
|
Control
|
P value
|
Treatment group
|
Control
|
p value
|
|---|
|
Number of animals analyzed
|
11
|
12
|
12
|
12
|
|---|
|
WBCs (× 103/μl)
|
11.17 ± 3.46
|
11.07 ± 1.79
|
0.93
|
8.26 ± 1.26
|
8.26 ± 1.26
|
0.51
|
|
RBCs (× 106/μl)
|
5.91 ± 0.71
|
6.33 ± 0.69
|
0.17
|
6.42 ± .40
|
6.42 ± 0.40
|
0.22
|
|
HGB (g/dl)
|
11.08 ± 0.95
|
11.60 ± 1.07
|
0.23
|
12.31 ± .84
|
12.31 ± 0.84
|
1.0
|
|
HCT (%)
|
31.10 ± 3.05
|
31.46 ± 3.50
|
0.79
|
32.67 ± 2.03
|
32.67 ± 2.03
|
0.97
|
|
MCV (fl)
|
50.51 ± 1.91
|
50.20 ± 2.51
|
0.74
|
49.74 ± 1.14
|
49.74 ± 1.14
|
0.86
|
|
MCH (pg)
|
18.79 ± 1.54
|
17.60 ± 1.49
|
0.07
|
19.61 ± .85
|
19.61 ± .85
|
1.0
|
|
MCHC (g/dl)
|
36.64 ± 0.97
|
36.42 ± 0.97
|
0.59
|
38.90 ± 1.23
|
38.90 ± 1.23
|
0.90
|
|
PLT (103/μl)
|
485.74 ± 60.97
|
505.42 ± 45.0
|
0.38
|
542.08 ± 70.93
|
542.08 ± 70.93
|
0.59
|
|
RDW (%)
|
12.51 ± 1.24
|
12.35 ± 1.17
|
0.75
|
11.31 ± .53
|
11.31 ± 0.53
|
0.67
|
|
Reticulocytes (%)
|
1.86 ± 0.28
|
1.85 ± 0.21
|
0.25
|
1.08 ± 0.16
|
1.08 ± 0.16
|
0.91
|
- IVD intervertebral disc; BM-cMSC bone marrow-derived clonal mesenchymal stromal cells; WBCs white blood cells; RBCs red blood cells; HGB hemoglobin; HCT hematocrit; MCV mean corpuscular volume; MCH mean corpuscular hemoglobin; MCHC mean corpuscular hemoglobin concentration; PLT platelets; RDW-CV red blood cell distribution width coefficient variation. P ≤ 0.05 indicates statistical significance
